Left ventricular mass and progenitor cells in chronic heart failure patients

Internal and Emergency Medicine

Volumn 10, Issue 3, 2015, Pages 329-335

  Michelucci, Antonio ^a   Cesari, Francesca ^a   Ricciardi, Giuseppe ^a   Attanà, Paola ^a   Pieragnoli, Paolo ^a   Ristalli, Francesca ^a   Padeletti, Luigi ^a   Gori, Anna Maria ^a,b   Gensini, Gian Franco ^a,b   Abbate, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Heart failure; Progenitor cells; Ventricular mass; Ventricular remodeling

Indexed keywords

ADULT; AGED; DIAGNOSTIC IMAGING; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HEART VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL; VASCULAR ENDOTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; STEM CELLS; VENTRICULAR REMODELING;

EID: 84939982993     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-014-1149-5     Document Type: Article

References (36)

1. Leone AM, Rutella S, Bonanno G, Contemi AM, de Ritis DG, Giannico MB, Rebuzzi AG, Leone G, Crea F (2006) Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol 111(2):202–208. doi:10.1016/j.ijcard.2005.06.043
2. Wyderka R, Wojakowski W, Jadczyk T, Maślankiewicz K, Parma Z, Pawłowski T, Musiałek P, Majka M, Król M, Kuczmik W, Dworowy S, Korzeniowska B, Ratajczak MZ, Tendera M (2012) Mobilization of CD34+CXCR4+ stem/progenitor cells and the parameters of left ventricular function and remodeling in 1-year follow-up of patients with acute myocardial infarction. Mediat Inflamm 2012:564027. doi:10.1155/2012/564027
3. Maltais S, Perrault LP, Ly HQ (2011) The bone marrow-cardiac axis: role of endothelial progenitor cells in heart failure. Eur J Cardiothorac Surg 39(3):368–374. doi:10.1016/j.ejcts.2010.04.022
4. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, Ratajczak J, Rezzoug F, Ildstad ST, Bolli R, Ratajczak MZ (2004) Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 10 95(12):1191–1199. doi:10.1161/01.RES.0000150856.47324.5b
5. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7(2):79–108. doi:10.1016/j.euje.2005.12.014
6. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458. doi:10.1016/0002-9149(86)90771-X
7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography (2005) J Am Soc Echocardiogr 18:1440–1463. doi:10.1016/j.echo.2005.10.005
8. Devereux RB, Pini R, Aurigemma GP, Roman MJ (1997) Measurement of left ventricular mass: methodology and expertise. J Hypertens 15(8):801–809
9. Cesari F, Caporale R, Marcucci R, Caciolli S, Stefano PL, Capalbo A, Macchi C, Vannucci M, Gensini GF, Abbate R, Gori AM (2008) NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells’ response to cardiac surgery. Atherosclerosis 199:138–146. doi:10.1016/j.atherosclerosis.2007.09.045
10. Cesari F, Sofi F, Caporale R, Capalbo A, Marcucci R, Macchi C, Lova RM, Cellai T, Vannucci M, Gensini GF, Abbate R, Gori AM (2009) Relationship between exercise capacity, endothelial progenitor cells and cytochemokines in patients undergoing cardiac rehabilitation. Thromb Haemost 101:521–526. doi:10.1160/TH08-10-0644
11. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5:213–226
12. Carroll JD, Hess OM (2005) Assessment of normal and abnormal cardiac function. In: Zipes DP, Libbey P, Bonow RO, Braunwald E et al. (eds) Braunwald's heart disease: a textbook of cardiovascular medicine (7th edition). Elsevier Saunders, Philadelphia, pp 491–507
13. Hirt MN, Sörensen NA, Bartholdt LM, Boeddinghaus J, Schaaf S, Eder A, Vollert I, Stöhr A, Schulze T, Witten A, Stoll M, Hansen A, Eschenhagen T (2012) Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol 107(6):307. doi:10.1007/s00395-012-0307-z
14. McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285(26):1441–1446. doi:10.1161/CIRCULATIONAHA.108.815944
15. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 119(24):3070–3077
16. Goette A, Jentsch-Ullrich K, Hammwöhner M, Trautmann S, Franke A, Klein HU, Auricchio A (2006) Cardiac uptake of progenitor cells in patients with moderate-to-severe left ventricular failure scheduled for cardiac resynchronization therapy. Europace 8(3):157–160. doi:10.1093/europace/euj042
17. Lee CW, Huang PH, Huang SS, Leu HB, Huang CC, Wu TC, Chen JW, Lin SJ (2011) Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy. Hypertens Res 34(9):999–1003. doi:10.1038/hr.2011.68
18. Huang PH, Huang SS, Chen YH, Lin CP, Chiang KH, Chen JS, Tsai HY, Lin FY, Chen JW, Lin SJ (2010) Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J Hypertens 28(8):1655–1665. doi:10.1097/HJH.0b013e32833a4d0a
19. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322(22):1561–1566. doi:10.1056/NEJM199005313222203
20. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP (1990) Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 81(3):815–820. doi:10.1161/01.CIR.81.3.815
21. Xu S, Zhu J, Yu L, Fu G (2012) Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy. J Cardiovasc Pharmacol 59(4):387–396. doi:10.1097/FJC.0b013e3182440338
22. Drawnel FM, Archer CR, Roderick HL (2013) The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol 168(2):296–317. doi:10.1111/j.1476-5381.2012.02195.x
23. Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N (2006) CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98(3):e20–e25. doi:10.1161/01.RES.0000205765.28940.93
24. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7(4):430–436. doi:10.1038/86498
25. Cohen KS, Cheng S, Larson MG, Cupples LA, McCabe EL, Wang YA, Ngwa JS, Martin RP, Klein RJ, Hashmi B, Ge Y, O’Donnell CJ, Vasan RS, Shaw SY, Wang TJ (2013) Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood 121(8):e50–e56. doi:10.1182/blood-2012-05-424846
26. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, Todo K, Mori K, Stern DM, Soma T, Naritomi H (2004) Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 109(24):2972–2975. doi:10.1182/blood-2012-05-424846
27. Cesari F, Nencini P, Nesi M, Caporale R, Giusti B, Abbate R, Gori AM, Inzitari D (2009) Bone marrow-derived progenitor cells in the early phase of ischemic stroke: relation with stroke severity and discharge outcome. J Cereb Blood Flow Metab 29(12):1983–1990. doi:10.1016/j.ejcts.2010.01.046
28. Ballard VL, Edelberg JM (2007) Stem cells and the regeneration of the aging cardiovascular system. Circ Res 27 100(8):1116–1127. doi:10.1161/01.RES.0000261964.19115.e3
29. Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter JA, Wang Y, Coffey AC, Meldrum DR (2010) Gender dimorphisms in progenitor and stem cell function in cardiovascular disease. J Cardiovasc Transl Res 3(2):103–113. doi:10.1007/s12265-009-9149-y
30. Cohen KS, Cheng S, Larson MG, Cupples LA, McCabe EL, Wang YA, Ngwa JS, Martin RP, Klein RJ, Hashmi B, Ge Y, O’Donnell CJ, Vasan RS, Shaw SY, Wang TJ (2013) Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood 121(8):e50–e56. doi:10.1182/blood-2012-05-424846
31. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I, Cignarella A, Bolego C, Plebani M, Nardelli GB, Sartore S, Agostini C, Avogaro A (2008) Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 28(5):997–1004. doi:10.1161/ATVBAHA.107.159558
32. Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, Reichart B, Steinbeck G, Franz WM (2007) Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 28(10):1258–1264. doi:10.1093/eurheartj/ehm011
33. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S (2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103(24):2885–2890. doi:10.1161/hc2401.092816
34. Xu H, Yang YJ, Yang T, Qian HY (2013) Statins and stem cell modulation. Ageing Res Rev 12(1):1–7. doi:10.1016/j.arr.2012.03.006
35. Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM (2007) Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 49(24):2341–2349. doi:10.1016/j.jacc.2007.01.095
36. Barsotti MC, Santoni T, Picoi ME, Mancini N, Massaro F, Grigoratos C, Bortolotti U, Collecchi P, Menicagli M, Scatena C, Felice F, Bevilacqua G, Naccarato AG, Di Stefano R, Balbarini A (2014) Endothelial progenitor cell homing in human myocardium in patients with coronary artery disease. Int J Cardiol 172(2):516–517. doi:10.1016/j.ijcard.2014.01.042